Author Question: Why is the term follower used infrequently in writings about adaptive leadership? a. It is a ... (Read 129 times)

lilldybug07

  • Hero Member
  • *****
  • Posts: 546
Why is the term follower used infrequently in writings about adaptive leadership?
 
  a. It is a derogatory term
  b. Follower implies a submissive role
  c. It lessens the role of the leader
  d. It presumes

Question 2

Compare and contrast the laissez-faire leader discussed in the transformation approach and the delegating leader discussed in the Situational Leadership Model.
 
  What will be an ideal response?



Bison

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

B

Answer to Question 2

They are similar because both types of leaders are nondirective and not controlling of subordinates. Both laissez-faire and delegative leaders allow subordinates to set their own goals and to select their own ways of achieving them. They are dissimilar because laissez-faire leaders abdicate responsibility, give no feedback, and make little effort to help followers satisfy their needs, while delegative leaders make themselves available to subordinates, give feedback when asked, and accept responsibility for the well-being and goal accomplishments of their subordinates.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library